Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2265462rdf:typepubmed:Citationlld:pubmed
pubmed-article:2265462lifeskim:mentionsumls-concept:C1148673lld:lifeskim
pubmed-article:2265462lifeskim:mentionsumls-concept:C0870883lld:lifeskim
pubmed-article:2265462lifeskim:mentionsumls-concept:C0057856lld:lifeskim
pubmed-article:2265462lifeskim:mentionsumls-concept:C0109896lld:lifeskim
pubmed-article:2265462pubmed:issue3lld:pubmed
pubmed-article:2265462pubmed:dateCreated1991-2-12lld:pubmed
pubmed-article:2265462pubmed:abstractTextThe quadrivalent second-generation platinum complex iproplatin and an in vivo divalent metabolite of iproplatin, cis-dichloro-bis-isopropylamine platinum (CIP) were tested for binding to DNA in vitro. DNA binding was determined according to radioactivity measured using [14C]-iproplatin and [14C]-CIP and also by platinum content. Results indicate that (a) iproplatin shows negligible binding to DNA, (b) CIP binds to DNA in a time-dependent fashion, and (c) the isopropylamine ligand is intact when CIP is bound to DNA. Glutathione (GSH) inhibits the binding of CIP to DNA, possibly by inhibiting binding to DNA of the aquated form of CIP.lld:pubmed
pubmed-article:2265462pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:languageenglld:pubmed
pubmed-article:2265462pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:citationSubsetIMlld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2265462pubmed:statusMEDLINElld:pubmed
pubmed-article:2265462pubmed:issn0344-5704lld:pubmed
pubmed-article:2265462pubmed:authorpubmed-author:CreavenP JPJlld:pubmed
pubmed-article:2265462pubmed:authorpubmed-author:PendyalaLLlld:pubmed
pubmed-article:2265462pubmed:authorpubmed-author:SansonePPlld:pubmed
pubmed-article:2265462pubmed:authorpubmed-author:CowensJ WJWlld:pubmed
pubmed-article:2265462pubmed:authorpubmed-author:ArakaliA VAVlld:pubmed
pubmed-article:2265462pubmed:issnTypePrintlld:pubmed
pubmed-article:2265462pubmed:volume27lld:pubmed
pubmed-article:2265462pubmed:ownerNLMlld:pubmed
pubmed-article:2265462pubmed:authorsCompleteYlld:pubmed
pubmed-article:2265462pubmed:pagination248-50lld:pubmed
pubmed-article:2265462pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:meshHeadingpubmed-meshheading:2265462-...lld:pubmed
pubmed-article:2265462pubmed:year1990lld:pubmed
pubmed-article:2265462pubmed:articleTitleDNA binding of iproplatin and its divalent metabolite cis-dichloro-bis-isopropylamine platinum (II).lld:pubmed
pubmed-article:2265462pubmed:affiliationDepartment of Medicine, Roswell Park Memorial Institute, Buffalo, NY 14263.lld:pubmed
pubmed-article:2265462pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2265462pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2265462pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2265462pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2265462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2265462lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2265462lld:pubmed